Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R J
Right arrow Articles by Hillmen, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R J
Right arrow Articles by Hillmen, P
Molecular Pathology 2002;55:145-152
© 2002 Journal of Clinical Pathology


REVIEW

Paroxysmal nocturnal haemoglobinuria: Nature's gene therapy?

R J Johnson1 and P Hillmen2

1 Department of Haematology, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK
2 Haematological Malignancy Diagnostic Service, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK

Correspondence to:
Dr R J Johnson, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK;
johnsonr{at}heartsol.wmids.nhs.uk


ABSTRACT
The development of paroxysmal nocturnal haemoglobinuria (PNH) requires two coincident factors: somatic mutation of the PIG-A gene in one or more haemopoietic stem cells and an abnormal, hypoplastic bone marrow environment. When both of these conditions are met, the fledgling PNH clone may flourish. This review will discuss the pathophysiology of this disease, which has recently been elucidated in some detail.


Keywords: paroxysmal nocturnal haemoglobinuria; PIG-A gene; aplastic anaemia

Abbreviations: AA, aplastic anaemia; ER, endoplasmic reticulum; GPI, glycosyl phosphatidylinositol; GlcNAc, N-acetylglucosamine; PEA, phosphoethanolamine; PI, phosphatidylinositol; PNH, paroxysmal nocturnal haemoglobinuria; VSG, variant surface glycoprotein




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
L. Bao, Y. Wang, A. Chang, A. W. Minto, J. Zhou, H. Kang, M. Haas, and R. J. Quigg
Unrestricted C3 Activation Occurs in Crry-Deficient Kidneys and Rapidly Leads to Chronic Renal Failure
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 811 - 822.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
R. A. Brodsky
New Insights into Paroxysmal Nocturnal Hemoglobinuria
Hematology, January 1, 2006; 2006(1): 24 - 28.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Hu, G. L. Mukhina, S. Piantadosi, J. P. Barber, R. J. Jones, and R. A. Brodsky
PIG-A mutations in normal hematopoiesis
Blood, May 15, 2005; 105(10): 3848 - 3854.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. N. Cunningham and R. J. Quigg
Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1214 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. S Krauss
Laboratory Diagnosis of Paroxysmal Nocturnal Hemoglobinuria
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 401 - 406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.